font size
Sign inprintPrint
Columns

 

BUSINESS STRATEGY:

Playing Chicken

For high risk technologies, it may take years to reach a commercial deal and the companies that pursue them may need to rely on alternatives to venture financing to carry them there.

Read More
  • Playing Chicken
    For high risk technologies, it may take years to reach a commercial deal and the companies that pursue them may need to rely on alternatives to venture financing to carry them there.
    March 13, 2009 - DANIEL S. LEVINE - Business - Business Strategy
  • The Best Column You've Ever Read
    Research shows expectations are important, after findings that a placebo work better when patients think it's an expensive drug.
    March 12, 2008 - DANIEL S. LEVINE - Policy / Law - Healthcare Reform
  • YouTube for the Lab Set
    Website JoVE.com seeks to make experiments more reproducible through videos in hopes of speeding drug discovery.
    February 29, 2008 - DANIEL S. LEVINE - Tech/Innovation - Research
  • A Healthcare System that Doesn't Value Health    
    A letter from the publishers
    January 08, 2008 - DAVID GOLLAHER AND G. STEVEN BURRILL - Health - Wellness
  • Fix-Me-Itis    
    A letter from the editor
    January 03, 2008 - WILLIAM PATRICK - Health - Wellness
  • A Letter to My Wife, the Doctor
    Some gentle advice to a physician about caring for a very special patient during flu season.
    December 14, 2007 - DANIEL S. LEVINE - Health - Medical Practice
  • History Lessons
    As government's role in healthcare grows, the controversy surrounding proposed plans may have less to do with who pays for it than who proposes it.
    November 07, 2007 - DAVID GOLLAHER - Health - Healthcare Reform
  • Targeted Chemotherapy
    Genentech looks to build a drug delivery platform with its monoclonal antibodies, and technology to link them to potent cancer drugs.
    November 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • Licensed to Cure
    Southern Research Institute sees a role for itself in bridging the academic and corporate worlds.
    September 26, 2007 - DANIEL S. LEVINE - Tech/Innovation - Research
  • Old Love
    Study finds majority of elderly Americans remain sexually active as health, rather than age, is the limiting factor.
    August 22, 2007 - DANIEL S. LEVINE - Society - Research
  • Beyond Steroids
    World Anti-Doping Agency turns its attention to detecting illicit gene doping.
    August 10, 2007 - DANIEL S. LEVINE - Society - Culture
  • Amgen Feeling Anemic
    Reimbursement restrictions could trigger a wallop from private payers.
    August 06, 2007 - DANIEL S. LEVINE - Policy / Law - Regulatory
  • A Modest Proposal
    Two oncologists want to address the high cost of drugs with a glass of grapefruit juice and the pharmaceutical industry should worry.
    July 16, 2007 - DANIEL S. LEVINE - Tech/Innovation - Medical Economics
  • Moore Problems
    Sicko opens the debate on universal healthcare as election season approaches.
    July 06, 2007 - DANIEL S. LEVINE - Health - Healthcare Reform

  • Hedge fund managers seek to spur innovation in cancer research through $1 million prize.
    June 01, 2007 - DANIEL S. LEVINE - Health - Innovation
  • Going Postal on Medical Costs
    The CEO of the largest mail-meter company is changing the face of healthcare.
    May 09, 2007 - DANIEL S. LEVINE - Health - Healthcare Reform
  • Mixing Molecular Metaphors
    Andrew von Eschenbach says the FDA needs to change.
    May 07, 2007 - DANIEL S. LEVINE - Policy / Law - Regulatory